Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein
Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein Summary
Product Specifications
Val26-Val200
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8417-IL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
8417-IL/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: IL-28A/IFN-lambda 2
IL‑28A (Interferon-lambda 2; IFN-lambda 2), IL-28B/IFN-lambda 3, and IL-29/IFN-lambda 1 are type III interferons which are distantly related to IL-10 family and type I IFN family cytokines (1‑3). Mature human IL-28A is an approximately 22-25 kDa protein that shares 66% amino acid (aa) sequence identity with mouse and rat IL-28A and shows cross-species activity (4). It shares 96% and 70% aa sequence identity with human IL-28B and IL-29, respectively. Type III interferons are upregulated in response to viral infection, and they act predominantly on epithelial cells through a receptor complex that contains IL-10 R beta and IL-28 R alpha /IFN-gamma R1 (4-6). Type III IFNs function as anti-viral molecules and induce the upregulation of MHC class I antigen (4, 5, 7). IL-28A promotes the Th1 polarization of dendritic cells in the airway (e.g. production of IL-12 p70 and IFN-gamma ) and inhibits Th2 and Th17 mediated inflammation (8). In the liver, however, the IL-28A induced Th1 cytokine response contributes to inflammation in T cell mediated hepatitis (9). IL-28A additionally exhibits anti-tumor activity, in part by enhancing IL-12 dependent anti-tumor CTL responses in vivo (10-12). In contrast, it is up-regulated in invasive bladder cancer where it promotes tumor cell migration (13).
- Durbin, R.K. et al. (2013) Immunol. Rev. 255:25.
- Li, Q. et al. (2013) Front. Biosci. (Landmark Ed.) 18:909.
- Lopusna, K. et al. (2013) Acta Virol. 57:171.
- Ank, N. et al. (2006) J. Virol. 80:4501.
- Sheppard, P. et al. (2003) Nature Immunol. 4:63.
- Kotenko, S.V. et al. (2003) Nature Immunol. 4:69.
- Pott, J. et al. (2011) Proc. Natl. Acad. Sci. USA 108:7944.
- Koltsida, O. et al. (2011) EMBO Mol. Med. 3:348.
- Siebler, J. et al. (2007) Gastroenterology 132:358.
- Sato, A. et al. (2006) J. Immunol. 176:7686.
- Tezuka, Y. et al. (2012) Lung Cancer 78:185.
- Numasaki, M. et al. (2007) J. Immunol. 178:5086.
- Lee, S.J. et al. (2012) PLoS ONE 7:e40267.
Citations for Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
3
Citations: Showing 1 - 3
Filter your results:
Filter by:
-
LRRC15 inhibits SARS-CoV-2 cellular entry in trans
Authors: J Song, RD Chow, M Pena-Herna, L Zhang, SA Loeb, EY So, OD Liang, P Ren, S Chen, CB Wilen, S Lee
PloS Biology, 2022-10-13;20(10):e3001805.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency
Authors: JH Chung, SH Hong, N Seo, TS Kim, HJ An, P Lee, EC Shin, HM Kim
Cytokine, 2019-08-31;125(0):154833.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
IFN-?4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling
Authors: AA Obajemu, N Rao, KA Dilley, JM Vargas, F Sheikh, RP Donnelly, RS Shabman, EG Meissner, L Prokunina-, OO Onabajo
J. Immunol., 2017-10-25;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein
There are currently no reviews for this product. Be the first to review Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein and earn rewards!
Have you used Recombinant Human IL-28A/IFN-lambda 2 (HEK293) Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image